SpicyIP

APRIL 7, 2024

She has been working in the field of access to medicines, patents and IP for more than a decade. This could make it harder to force companies to license patents if they are not being used to make affordable products in India. Prathibha Sivasubramanian is a law researcher working with TWN.

Patent 72

Patent Patent Application Intellectual Property Law 72

IP and Legal Filings

APRIL 20, 2022

The denial of the market entry often concerns the access to essential and cheaper medicines and in a larger picture, the public health issue. The availability of generic drugs being subjected to any such preceding condition irrespective of any infringement does affect the larger issues of access to medicine.

Patent 79

Patent Marketing Marketing IP 79

Patently-O

FEBRUARY 1, 2022

Companies and trade associations were broadly classified as “High Tech” (18%) or “Life Sciences” (14%). It should be no surprise to readers of Patently-O that many are unhappy with the Supreme Court’s jurisprudence regarding patent eligibility under Section 101 of the Patent Act. Methodology . Positive Comments .

Patent 120

Patent Invention Technology Marketing 120

SpicyIP

SEPTEMBER 25, 2023

Case Summaries Anil Kapoor vs Simply Life India & Ors on 20 September, 2023 (Delhi High Court) Image from here The Plaintiff sought protection of his personality rights, publicity rights and elements associated with his persona like his name, voice, photographs/ likeness, dialogues, manner of dialogue delivery, gestures, signatures.

Cease and Desist 105

Cease and Desist Copyright Infringement Invention Social Media 105

SpicyIP

JANUARY 23, 2024

The plaintiffs were the licensees of Ibrutinib, which was also being manufactured and sold by several generic medicine companies (defendants), without a license, under various brand names. Manmohan’s term expired on 21 September 2019, however, the Supreme Court in International Association for Protection of Intellectual Property v.

Intellectual Property 129

Intellectual Property Patent Blogging Marketing 129

SpicyIP

NOVEMBER 9, 2023

His previous post can be accessed here ]. Bedaquiline is also in the List of Essential Medicines by the World Health Organisation. According to a UNITAID report, there are at least 5 Janssen patents associated with bedaquiline. He has a keen interest in commercial laws, especially in IP and allied fields.

Patent 69

Patent Reporting Government Ownership 69

The IPKat

FEBRUARY 6, 2022

Topics will include access and substantial similarity, fair use, performers' rights, moral rights, expert testimony, the role of lay listeners, sound sampling as it appears in court and out-of-court litigation. For more information and to register, click here. More information and submission guidelines can be found here.

Intellectual Property 78

Intellectual Property Moral Rights Privacy Copyright Infringement 78

SpicyIP

OCTOBER 3, 2021

Due to the fact that medications like Zolgensma operate without a large enough target demographic to be addressed as public need, they do not get the necessary attention to have the accessibility issue addressed. Webinar on Digital Sequence Information (DSI): Implications on Access & Benefit Sharing [October 4-7].

Intellectual Property 121

Intellectual Property Licensing Music Copyright 121

LexBlog IP

APRIL 25, 2023

Direct Biologics sues former employee, his new employer Direct Biologics is a biotechnology company in the regenerative medicine field, which manufactures biologically derived pharmaceutical products, including stem cell therapies and tissue regeneration grafts.

Confidentiality 40

Confidentiality Litigation Marketing Marketing 40

SpicyIP

DECEMBER 20, 2023

Speaking of this, Siddharth Sonkar’s detailed post on whether a sui generis protection of unoriginal databases reconciles access and incentive to actualize public good is worth poring over. 400 crore war between Monsanto and Indian seed companies with threats of price control and compulsory licensing of patents.”

Personality Rights 59

Personality Rights IP Licensing Copyright 59

IP and Legal Filings

MARCH 7, 2022

It demonstrates to a buyer where a product came from and how much he can trust that product based on the brand value associated with it. It demonstrates to a buyer where a product came from and how much he can trust that product based on the brand value associated with it. Types Of Trademark Infringement. Remedies Available For Owner.

Trademark 61

Trademark Law Registering Trademarks Branding 61

IP and Legal Filings

MARCH 7, 2022

It demonstrates to a buyer where a product came from and how much he can trust that product based on the brand value associated with it. It demonstrates to a buyer where a product came from and how much he can trust that product based on the brand value associated with it. Types Of Trademark Infringement. Remedies Available For Owner.

Trademark 57

Trademark Law Registering Trademarks Branding 57

Fish & Richardson Trademark & Copyright Thoughts

MARCH 8, 2021

The authors also look to lawmakers at the federal and state levels, who considered a variety of legislative proposals relating to biologics and biosimilars designed to improve patient access, encourage commercialization, and reduce costs. Regulatory And Legislative Actions Set The Tone For Biosimilars in 2021. Biosimilar Regulatory Updates.

Settlement 40

Settlement Licensing Designs Design 40

LexBlog IP

JULY 8, 2021

Providing trademarks on goods or in association of services, and webpage printouts or photographs of the same, suffices as proof of use. This mitigates the potential risk associated with losing a trademark name by waiting until the product release date to file a trademark. Conclusion. 1(b) – No use of mark yet, intending to use”. “44(d)

Trademark 52

Trademark Registration Web Development Advertising 52

Velocity of Content

OCTOBER 13, 2022

Recently, CCC hosted senior leaders from Eli Lilly and Company’s Legal and Library teams for an engaging panel discussion exploring how they partner to empower teams across the various phases of the drug development pipeline. Dr. John Rudolph – Associate Vice President and Assistant General Counsel, Trademarks.

Licensing 88

Licensing Copyright Copying Journalism 88

SpicyIP

MARCH 10, 2023

Image from here As the World Intellectual Property Organisation (WIPO) gears up for the preparatory work leading up to the Diplomatic Conference on Genetic Resources and Associated Traditional Knowledge in 2024, the world could learn some lessons from a pending legislation in India which aims to amend the Biological Diversity Act, 2002.

Intellectual Property 105

Intellectual Property Government Law Publishing 105

SpicyIP

SEPTEMBER 5, 2022

Both companies have enjoyed windfall financial gain from the sale of their respective vaccines. Both companies have enjoyed windfall financial gain from the sale of their respective vaccines. Moderna was one such company that was granted a compulsory license. Moderna was set up in 2010 with its sole focus being mRNA technology.

Litigation 137

Litigation Patent Technology Ownership 137

LexBlog IP

AUGUST 12, 2021

A group of senators, led by Senator Amy Klobuchar, are sponsors of a Senate bill which aims to prohibit biological product manufacturers from compensating biosimilar and interchangeable biological companies in exchange for delaying entry of those biosimilar and interchangeable biological products. 1428, 117th Cong.

Settlement 52

Settlement Intellectual Property Law Intellectual Property Reporting 52

IIPRD

MAY 4, 2023

Patenting of medical devices Medical device companies continue to value patents as the strongest form of intellectual property for their mechanical devices, such as catheters, heart valves, spinal implants, neurovascular coils and many others. Medical devices are patentable in India with certain caveats.

Intellectual Property 52

Intellectual Property Invention Public Domain Patent 52

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

Introduction. The biosimilar pathway was designed to increase competition for biologics and reduce healthcare costs. Yet 2020 saw a slowdown in biosimilar activity with the lowest number of annual biosimilar approvals since 2016 and fewer product launches than 2019—as well as a decrease in district court litigation and post-grant proceedings.

Settlement 52

Settlement Litigation Marketing Marketing 52

Kluwer Copyright Blog

MARCH 6, 2023

Enabling medical discovery Medical researchers often use TDM to investigate new uses of medicines and other treatments that can lead to important breakthroughs. An extensive study of research exceptions in over 190 countries shows that copyright may be a hindrance to certain kinds of TDM research in most of the countries of the world today.

Copyright 122

Copyright Social Media Publishing Licensing 122

IIPRD

JUNE 22, 2021

associated with them. Overview of discussions about the IP waiver: The major challenges in the access of vaccines, diagnostics, and therapeutics are availability, cost, barriers to local production, and logistics infrastructure challenges. The same is the case with the proposal and its unanimous acceptance is still awaited.

IP 40

IP Intellectual Property Technology Patent 40

SpicyIP

JANUARY 8, 2024

Her previous posts can be accessed here. Further, since Visa International Service Association, the proprietor of one of the cited conflicting “VISA” mark, did not have any objections against the appellant’s mark, the Court directed for it to be registered as a trademark. Vedika is a third-year B.A.LL.B.

Trademark 59

Trademark Registering Trademarks Public Domain Registration 59

SpicyIP

DECEMBER 30, 2023

The decisions in the first category, i.e., Top 10 IP Cases/Judgements (Topicality/Impact) reflect those that we thought were important from a topical point of view and were covered by the media in some way owing to the importance of parties litigating or the issue being considered or for impact on industry and innovation/creativity ecosystem etc.

IP 124

IP Copyright Trademark Intellectual Property 124

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 11, 2022

Several other companies have also announced plans to pursue interchangeable status for biosimilar products. Consistent with this, as shown below in Table 2, numerous companies have publicly announced the submission and/or acceptance of new biosimilar BLAs. Zarxio ® (Sandoz). Neupogen ® (Amgen). filgrastim-sndz. March 6, 2015.

Litigation 52

Litigation Settlement Patent Marketing 52

Technology & Marketing Law Blog

MARCH 28, 2022

When a general disclosure law prompts a company to change its behavior (which sometimes is the legislature’s hope or intent), those changes don’t necessarily impact the company’s speech outputs. ” “There is a fortune waiting for any company that creates a successful alternative to the Platforms.

Social Media 104

Social Media Publishing Law Blogging 104

43(B)log

FEBRUARY 3, 2024

Andrew Gilden, Talking Pleasure in IP Courts and advocates are skeptical of value of pleasure; when they want to honor it, they reframe it as something else, like social justice. Joy of producing/consuming can be important motivation for activities, though, so exploring how courts deal with it in IP is important. Moralistic?

IP 59

IP Marketing Marketing Patent 59